G. de Laroche

发表

A controlled ‘before-after’ study: impact of a clinical guidelines programme and regional cancer network organization on medical practice

B. Fervers, I. Ray-Coquard, G. Browman, 2002, British Journal of Cancer.

Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-choline for guiding target volume delineation.

N. Magné, A. Vallard, C. Chargari, 2016, The British journal of radiology.

Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey

N. Magné, A. Vallard, G. de Laroche, 2018, Scientific Reports.

Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trial.

V. Boige, S. Gourgou-Bourgade, J. Gérard, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy of rectal cancer in elderly patients: Real-world data assessment in a decade.

N. Magné, A. Vallard, G. de Laroche, 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region

J. Blay, P. Biron, I. Ray-Coquard, 2010, BMC Cancer.

Translating Clinical Evidence-Based Medicine into the Real World: Single-Center Experience with Cabazitaxel in Metastatic Prostate Cancer Patients

N. Magné, P. Fournel, G. de Laroche, 2016, Chemotherapy.

[Exclusive radiotherapy and concurrent endocrine therapy for the management of elderly breast cancer patients: case study and review of hypofractionated schemes].

N. Magné, Cyrus Chargari, C. Chauleur, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Radiotherapy for gynecologic cancer in nonagenarian patients: a framework for new paradigms

N. Magné, Cyrus Chargari, R. Rivoirard, 2016, Chinese journal of cancer.

[Establishment of a pilot study of awareness retraining in physical activity in two selected populations of patients with breast cancer].

N. Magné, F. Roche, M. Garet, 2012, Bulletin du cancer.

Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07).

F. Denis, D. Pasquier, V. Beckendorf, 2019, International journal of radiation oncology, biology, physics.

High expression of gabarapl1 is associated with a better outcome for patients with lymph node-positive breast cancer

A. Sasco, M. Jouvenot, G. Laroche, 2010, British Journal of Cancer.

Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.

B. Dubray, S. Guérif, A. Ruffion, 2016, The Lancet. Oncology.

[Internal mammary chain irradiation in breast cancer: state of the art].

N. Magné, Cyrus Chargari, Y. Kirova, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Plasminogen activator inhibitor type 1 is the most significant of the usual tissue prognostic factors in node-negative breast ductal adenocarcinoma independent of urokinase-type plasminogen activator.

B. Riche, G. de Laroche, S. Saez, 2008, Clinical breast cancer.

Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity.

J. Bourhis, D. Stoppa-Lyonnet, A. Puisieux, 2016, International journal of radiation oncology, biology, physics.

Persistence of medical change at implementation of clinical guidelines on medical practice: a controlled study in a cancer network.

I. Ray-Coquard, F. Chauvin, A. Lurkin, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes prediction in pre-operative radiotherapy locally advanced rectal cancer: leucocyte assessment as immune biomarker

N. Magné, M. Péoc'h, A. Vallard, 2018, Oncotarget.

Comprehensive Geriatric Assessment and quality of life after localized prostate cancer radiotherapy in elderly patients

N. Magné, E. Deniaud-Alexandre, Y. Belkacemi, 2018, PloS one.

From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience

N. Magné, A. Vallard, C. Chauleur, 2018, Radiation Oncology.

[Intra-abdominal desmoplastic small round-cell tumors. An entity among peritoneal carcinomatoses in young adults].

G. de Laroche, J. Jacquin, J. Garnier, 2000, Gastroenterologie clinique et biologique.

Volumetric modulated arc radiotherapy for limited osteosclerotic myeloma.

N. Magné, Cyrus Chargari, A. Levy, 2013, World journal of radiology.

[Magnetic resonance imaging for delineation of prostate in radiotherapy: monocentric experience and review of literature].

N. Magné, Cyrus Chargari, B. Leduc, 2012, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Real-life assessment of Volumetric Modulated Arc Therapy (VMAT) toxicity in Head and Neck Squamous Cell Carcinoma (HNSCC) treatment

N. Magné, P. Fournel, A. Vallard, 2016, Acta oto-laryngologica.

Curative‐Intended Treatment of Squamous Cell Anal Carcinoma in Elderly Adults

N. Magné, Cyrus Chargari, A. Levy, 2012, Journal of the American Geriatrics Society.

[Supra- and infraclavicular lymph node irradiation in breast cancer patients: state of the art].

N. Magné, Y. Kirova, C. Chargari, 2012, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Iridium curietherapy in conservative treatment of infiltrating cancer of the bladder].

P. Romestaing, J. Gérard, J. Auque, 1985, Journal d'urologie.

[Screening psychological distress in breast cancer patients on treatment].

N. Magné, P. Michaud, S. Lallich, 2015, Bulletin du cancer.

Curative treatment of carcinoma of the prostate with an association of external irradiation, iridium implant and lymphadenectomy.

P. Romestaing, J. Gérard, F. Mornex, 1987, Progress in clinical and biological research.

Outcomes and treatments of IB1 cervical cancers with high recurrence risk: A 13 years' experience.

N. Magné, A. Vallard, C. Chauleur, 2018, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Correlation of dosimetric parameters obtained with the analytical anisotropic algorithm and toxicity of chest chemoradiation in lung carcinoma.

N. Magné, Cyrus Chargari, P. Fournel, 2012, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

990PDIMPACT OF CLINICAL PRACTICE GUIDELINE'S ON MEDICAL PRACTICE AND SURVIVAL FOR HEAD AND NECK CANCER MANAGEMENT IN FISRT LINE TREATMENT (N = 1121 PATIENTS).

X. Pivot, I. Ray-Coquard, E. Reyt, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience

N. Magné, A. Vallard, G. de Laroche, 2018, Radiation oncology.

Correction to: From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience

N. Magné, A. Vallard, C. Chauleur, 2018, Radiation oncology.